• COVID-19 Anterior nasal swab – Sensitivity 93.8%, Specificity 100%
• COVID-19 Nasopharyngeal – Sensitivity 93.1%, Specificity 100%
• Flu A – Sensitivity 91.4%, Specificity 95.7%
• Flu B – Sensitivity 87.6%, Specificity 95.9%
• FDA Emergency Use Authorization (EUA)
• Visually read in 15 minutes
• Flocked nasopharyngeal swab for superior specimen collection and patient comfort

• Ready to use on site test for Monitoring microbial contamination
• Easy result interpretation
• Decease costly disposal of unstable fluids
• Incubate at 36°C for up to 24 hours
• Option to incubate at room temperature for up to 5 days

Our products are developed and manufactured in the USA under ISO, FDA, cGMP, and CE mark guidelines. BDSC’s team of expert sales, technical and customer service professionals are devoted to delivering the highest quality of service to our partners.

BDSC is an authorized distributor delivering high quality rapid point of care testing products to the healthcare industry. BDSC’s line of innovative products is used by clinicians to aid in the detection of medical conditions which include Infectious Disease, Women’s Health, and Cardiac Markers. The vast majority of our products are developed and manufactured in the USA under ISO, FDA, cGMP, and CE mark guidelines. BDSC’s team of sales, technical, and customer service professionals deliver the highest quality of service and support to our customers.

BDSC Company offers a range of ordering options. If you would like to speak to a BDSC expert immediately, contact us on 800-592-1041. If you prefer to enquire online, please click on ‘Get A Quote’ above.